SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193805-08-000865
Filing Date
2008-03-14
Accepted
2008-03-14 16:31:35
Documents
1
Group Members
DEERFIELD CAPITAL, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITEDDEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e603506_13ga-cyclacel.txt SC 13G/A 27480
  Complete submission text file 0001193805-08-000865.txt   29660
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80136 | Film No.: 08689870
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 212-551-1600
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A